Recent studies have reported elevated expression of EGFL7 in several tumors and cancer cell lines, including kidney tumors, malignant gliomas, hepatocellular carcinomas, and colon cancers [7]−[10]. This evidence concerns the gene EGFL7 and hepatocellular carcinoma.